Skip to content
Screener

Total Revenue at other companies

ITG
Integer HoldingsITGR
$439.58M+0.5%
Abbott logo
AbbottABT
$12.59B+13.0%
Baxter International logo
Baxter InternationalBAX
$2.7B+2.9%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$4.98B-9.5%
Edwards Lifesciences logo
Edwards LifesciencesEW
$1.74B+13.6%
Medtronic logo
MedtronicMDT
$9.81B+9.9%

Segments

By geography

See full
US$36.66M
DE$4.46M
CA$3.96M
GB$3.3M

Other financials

Income statement

See full
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation

See full
Market cap$1.85B-12.4%
Enterprise value$1.84B-12.3%
P/E28.1×-16.6×
P/S-2.0×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333762
Line itemThree months ended / June 30, 2026Three months ended / June 30, 2025Six months ended / June 30, 2026Six months ended / June 30, 2025
Net sales$70,382$64,232$136,933$124,103
Cost of sales19,61819,25837,77337,709
Gross profit50,76444,97499,16086,394
Sales and marketing14,40814,89528,92329,107
General and administrative11,11010,39623,15620,883
Research and development4,8473,5418,9077,636
Total operating expenses30,36528,83260,98657,626
Income from operations20,39916,14238,17428,768

Item 1. Financial Statements

FAQ

What is LeMaitre Vascular's total revenue?
LeMaitre Vascular (LMAT) reported total revenue of $70.38M in Q2 2026.
How has LeMaitre Vascular's total revenue changed year-over-year?
LeMaitre Vascular's total revenue increased by 9.6% year-over-year, from $64.23M to $70.38M.
What is the long-term trend for LeMaitre Vascular's total revenue?
Over 4 years (2021 to 2025), LeMaitre Vascular's total revenue has grown at a 12.8% compound annual growth rate (CAGR), from $154.42M to $249.6M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about LeMaitre Vascular's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude